
|Videos|January 14, 2015
Pipeline Antimicrobials Addressing Resistant Bacteria Threats
J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, discusses which pipeline antimicrobials are addressing resistant bacteria threats.
Advertisement
J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, discusses which pipeline antimicrobials are adressing resistant bacteria threats.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Nufymco, Interchangeable Ranibizumab Biosimilar, for Retinal Diseases
2
Achieving Optimal LDL-C Helps Prevent Neoatherosclerosis, Late Stent Failure in Patients With STEMI
3
FDA Approves First Oral GLP-1 for Weight Management
4
FDA Approves Milestone Oral Therapy for Adults With Thalassemia Anemia
5







































































































































































































